Chief Clinical Research Officer & Lymphoma Clinical Innovations Lab head At Olivia Newton John Cancer Research Institute. Lymphoma Lead At ONJCancerCentre Lymphoma Researcher Monash University #lymsm #hemesky #medsky Views are my ownhttps://bsky.app/profile/elizahawkes.bsky.socialhttps://bsky.app/profile/elizahawkes.bsky.social/post/3m5f6az5er223Dr Zoe Loh kicked off her PhD with this review of newer MCL biomarkers in the era of targeted therapies. Great expert input also from Dr Paul yeh and A/Prof Colm Keane. @onjcri.org.au https://haematologica.org/haematologica/article/view/1298011 Nov 2025 22:20 +0000at://did:plc:hbf5nwnchhwglcflbczfslry/app.bsky.feed.post/3m5f6az5er223https://bsky.app/profile/elizahawkes.bsky.social/post/3m4fvzhqkgc2jOur fantastic @onjcri.org.au and @lardr.bsky.social teams presenting lymphoma research orals at #HSANZ Blood conference in Perth. Dr Liz Goodall, Dr Allison barraclough, Eliza Chung and Rebecca nightingale and Dr Arina Martynchyk. All rising @womeninlymphoma.bsky.social30 Oct 2025 12:00 +0000at://did:plc:hbf5nwnchhwglcflbczfslry/app.bsky.feed.post/3m4fvzhqkgc2jhttps://bsky.app/profile/elizahawkes.bsky.social/post/3lz6ksouakc2zThanks to Dr Yamshon and @johnpleonardmd.bsky.social for your excellent editorial: Unstacking the deck in follicular lymphoma clinical trials url: https://academic.oup.com/jnci/article/doi/10.1093/jnci/djaf231/8253283 In response to our paper here: https://academic.oup.com/jnci/article-abstract/doi/10.1093/jnci/djaf174/819616719 Sep 2025 09:35 +0000at://did:plc:hbf5nwnchhwglcflbczfslry/app.bsky.feed.post/3lz6ksouakc2zhttps://bsky.app/profile/elizahawkes.bsky.social/post/3luadkcq5xk2zT‐Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B‐Cell Lymphoma - Wight - 2025 - eJHaem - Wiley Online Library https://onlinelibrary.wiley.com/doi/10.1002/jha2.7009718 Jul 2025 11:25 +0000at://did:plc:hbf5nwnchhwglcflbczfslry/app.bsky.feed.post/3luadkcq5xk2zhttps://bsky.app/profile/elizahawkes.bsky.social/post/3luadf2rwes2zMeeting trial eligibility in follicular lymphoma patients is associated with overall survival but not progression-free survival url: https://academic.oup.com/jnci/article-abstract/doi/10.1093/jnci/djaf174/819616718 Jul 2025 11:22 +0000at://did:plc:hbf5nwnchhwglcflbczfslry/app.bsky.feed.post/3luadf2rwes2zhttps://bsky.app/profile/elizahawkes.bsky.social/post/3lscjx5mkuc2rOur multidisciplinary study of RT + immunotherapy with CD8 PET as a biomarker of response in relapse B-NHL https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2025016505/537883/T-cell-dysregulation-informs-radiotherapy23 Jun 2025 21:34 +0000at://did:plc:hbf5nwnchhwglcflbczfslry/app.bsky.feed.post/3lscjx5mkuc2rhttps://bsky.app/profile/elizahawkes.bsky.social/post/3lq6npgten225Pleased to work with my U.K. colleagues this analysis of PET data from our CHEMO-T study in PTCL led by #drgleeson and #drchua https://onlinelibrary.wiley.com/doi/10.1111/bjh.2016027 May 2025 21:40 +0000at://did:plc:hbf5nwnchhwglcflbczfslry/app.bsky.feed.post/3lq6npgten225https://bsky.app/profile/elizahawkes.bsky.social/post/3lojpvlxsmc2cOur study showing 3D volume assessment of PCNSL on MRI is more accurate than standard criteria in response assessment and prognostication. https://academic.oup.com/noa/advance-article/doi/10.1093/noajnl/vdaf090/8125156?utm_source=advanceaccess&utm_campaign=noa&utm_medium=email06 May 2025 20:28 +0000at://did:plc:hbf5nwnchhwglcflbczfslry/app.bsky.feed.post/3lojpvlxsmc2c